Updates on clinical studies of selenium supplementation in radiotherapy

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Puspitasari, Irma M ^a,b   Abdulah, Rizky ^a,b   Yamazaki, Chiho ^a   Kameo, Satomi ^a   Nakano, Takashi ^a   Koyama, Hiroshi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

Clinical studies; Radiotherapy; Selenium; Supplementation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CATALASE; CERULOPLASMIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 2 RECEPTOR; PLACEBO; RETINOL; SELENIUM; SODIUM SELENITE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ASIAN; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER PATIENT; CANCER RADIOTHERAPY; DIARRHEA; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE SEDIMENTATION RATE; EUROPEAN AMERICAN; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; FATIGUE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HAIR LOSS; HUMAN; IONIZING RADIATION; LONG TERM CARE; META ANALYSIS; MULTICENTER STUDY (TOPIC); NAIL COLOR DEFECT; NAUSEA; OBSERVATIONAL STUDY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE DATABASE; REVIEW; SELENIUM BLOOD LEVEL; SYSTEMATIC REVIEW; NEOPLASMS; RADIATION INJURIES;

DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY; SELENIUM;

EID: 84903548969     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-125     Document Type: Review

References (44)

1. Shirazi A, Ghobadi G, Ghazi-Khansari M. A radiobiological review on melatonin: a novel radioprotector. J Radiat Res 2007, 48:263-272. 10.1269/jrr.06070, 17641465.
2. Borek C. Antioxidants and radiation therapy. J Nutr 2004, 134:3207S-3209S.
3. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 2006, 6:702-713. 10.1038/nrc1950, 16929324.
4. Dörr W. Effects of selenium on radiation responses of tumor cells and tissue. Strahlenther Onkol 2006, 182:693-695. 10.1007/s00066-006-1595-8, 17149574.
5. Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann N Y Acad Sci 2000, 899:44-60.
6. Rayman MP. The importance of selenium to human health. Lancet 2000, 356:233-241. 10.1016/S0140-6736(00)02490-9, 10963212.
7. Breccia A, Badiello R, Trenta A, Mattii M. On the chemical radioprotection by organic selenium compounds in vivo. Radiat Res 1969, 38:483-492. 10.2307/3572608, 5790115.
8. Weiss JF, Srinivasan V, Kumar KS, Landauer MR. Radioprotection by metals: selenium. Adv Space Res 1992, 12:223-231.
9. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007, 9:775-806. 10.1089/ars.2007.1528, 17508906.
10. Arner ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000, 267:6102-6109. 10.1046/j.1432-1327.2000.01701.x, 11012661.
11. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 2005, 64:527-542. 10.1079/PNS2005467, 16313696.
12. Ponholzer A, Struhal G, Madersbacher S. Frequent use of complementary medicine by prostate cancer patients. Eur Urol 2003, 43:604-608. 10.1016/S0302-2838(03)00155-6, 12767359.
13. Micke O, Buntzel J, Kisters K, Schafer U, Micke P, Mucke R. Complementary and alternative medicine in lung cancer patients: a neglected phenomenon?. Front Radiat Ther Oncol 2010, 42:198-205.
14. Tabassum A, Bristow RG, Venkateswaran V. Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?. Cancer Treat Rev 2010, 36:230-234. 10.1016/j.ctrv.2009.12.008, 20079573.
15. Fritz H, Kennedy D, Fergusson D, Fernandes R, Cooley K, Seely A, Sagar S, Wong R, Seely D. Selenium and lung cancer: a systematic review and meta analysis. PLoS One 2011, 6:e26259. 10.1371/journal.pone.0026259, 3208545, 22073154.
16. Dennert G, Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev 2006, 3:CD005037.
17. Pothier L, Lane WW, Bhargava A, Michielson C, Douglass HO. Plasma selenium levels in patients with advanced upper gastrointestinal cancer. Cancer 1987, 60:2251-2260. 10.1002/1097-0142(19871101)60:9<2251::AID-CNCR2820600925>3.0.CO;2-T, 3440235.
18. Antila HM, Salo MS, Nanto V, Nikkanen V, Kirvela O. The effect of postoperative radiotherapy on leukocyte zinc, serum trace elements and nutritional status of breast cancer patients. Acta Oncol 1992, 31:569-572. 10.3109/02841869209088308, 1419104.
19. Piccinini L, Borella P, Bargellini A, Medici CI, Zoboli A. A case-control study on selenium, zinc, and copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Elem Res 1996, 51:23-30. 10.1007/BF02790144, 8834377.
20. Rostkowska-Nadolska B, Pospiech L, Bochnia M. Content of trace elements in serum of patients with carcinoma of the larynx. Arch Immunol Ther Exp (Warsz) 1999, 47:321-325.
21. Yadav SP, Gera A, Singh I, Chanda R. Serum selenium levels in patients with head and neck cancer. J Otolaryngol 2002, 31:216-219. 10.2310/7070.2002.21096, 12240756.
22. Last KW, Cornelius V, Delves T, Sieniawska C, Fitzgibbon J, Norton A, Amess J, Wilson A, Rohatiner AZ, Lister TA. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma. J Clin Oncol 2003, 21:2335-2341. 10.1200/JCO.2003.06.145, 12805335.
23. Fraunholz I, Eberlein K, Schopohl B, Bottcher HD, Rodel C. Selenium levels during the course of radiotherapy. No influence of irradiation on blood selenium concentration. Strahlenther Onkol 2008, 184:411-415. 10.1007/s00066-008-1867-6, 18956518.
24. Franca CA, Nogueira CR, Ramalho A, Carvalho AC, Vieira SL, Penna AB. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy. Ann Oncol 2011, 22:1109-1112. 10.1093/annonc/mdq547, 20924074.
25. Zeng YC, Xue M, Chi F, Xu ZG, Fan GL, Fan YC, Zheng MH, Zhong WZ, Wang SL, Zhang ZY, Chen XD, Wu LN, Jin XY, Chen W, Li Q, Zhang XY, Xiao YP, Wu R, Guo QY. Serum levels of selenium in patients with brain metastases from non-small cell lung cancer before and after radiotherapy. Cancer Radiother 2012, 3:179-182.
26. Eroglu C, Unal D, Cetin A, Orhan O, Sivgin S, Ozturk A. Effect of serum selenium levels on radiotherapy-related toxicity in patients undergoing radiotherapy for head and neck cancer. Anticancer Res 2012, 32:3587-3590.
27. Pakdaman A. Symptomatic treatment of brain tumor patients with sodium selenite, oxygen, and other supportive measures. Biol Trace Elem Res 1998, 62:1-6. 10.1007/BF02820015, 9630418.
28. Kiremidjian-Schumacher L, Roy M, Glickman R, Schneider K, Rothstein S, Cooper J, Hochster H, Kim M, Newman R. Selenium and immunocompetence in patients with head and neck cancer. Biol Trace Elem Res 2000, 73:97-111. 10.1385/BTER:73:2:97, 11049203.
29. Micke O, Bruns F, Mücke R, Schäfer U, Glatzel M, DeVries AF, Schönekaes K, Kisters K, Büntzel J. Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys 2003, 56:40-49. 10.1016/S0360-3016(02)04390-0, 12694822.
30. Elango N, Samuel S, Chinnakkannu P. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation. Clin Chim Acta 2006, 373:92-98. 10.1016/j.cca.2006.05.021, 16831410.
31. Muecke R, Schomburg L, Glatzel M, Berndt-Skorka R, Baaske D, Reichl B, Buentzel J, Kundt G, Prott FJ, Devries A, Stoll G, Kisters K, Bruns F, Schaefer U, Willich N, Micke O. Oncology-AKTE GWGTEaEi. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 2010, 78:828-835. 10.1016/j.ijrobp.2009.08.013, 20133068.
32. Büntzel J, Riesenbeck D, Glatzel M, Berndt-Skorka R, Riedel T, Mücke R, Kisters K, Schönekaes KG, Schäfer U, Bruns F, Micke O. Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients. Anticancer Res 2010, 30:1829-1832.
33. AMA Manual of Style A Guide for Authors and Editors 2007, New York: Oxford University Press, 10, AMA Manual of Style.
34. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Regulation of cellular immune responses by selenium. Biol Trace Elem Res 1992, 33:23-35. 10.1007/BF02783989, 1379457.
35. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Effect of selenium on the expression of high affinity interleukin 2 receptors. Proc Soc Exp Biol Med 1992, 200:36-43. 10.3181/00379727-200-43391, 1570357.
36. Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009, 89:2025S-2039S. 10.3945/ajcn.2009.27230F, 19420095.
37. Abdulah R, Miyazaki K, Nakazawa M, Koyama H. Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol 2005, 19:141-150. 10.1016/j.jtemb.2005.09.003, 16325529.
38. Akesson B, Bellew T, Burk RF. Purification of selenoprotein P from human plasma. Biochim Biophys Acta 1994, 1204:243-249. 10.1016/0167-4838(94)90014-0, 8142465.
39. Deagen JT, Butler JA, Zachara BA, Whanger PD. Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P, and albumin in plasma. Anal Biochem 1993, 208:176-181. 10.1006/abio.1993.1025, 8434786.
40. Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine DRI Dietary Referece Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids 2000, Washington D.C: National Academy Press, Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine.
41. Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002, 11:1285-1291.
42. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147:217-223. 10.7326/0003-4819-147-4-200708210-00175, 17620655.
43. Nuttall KL. Evaluating selenium poisoning. Ann Clin Lab Sci 2006, 36:409-420.
44. MacFarquhar JK, Broussard DL, Melstrom P, Hutchinson R, Wolkin A, Martin C, Burk RF, Dunn JR, Green AL, Hammond R, Schaffner W, Jones TF. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med 2010, 170:256-261. 10.1001/archinternmed.2009.495, 3225252, 20142570.